Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 10:48 am EDT
Share
Qingdao Haier Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 563.45 million compared to CNY 413.63 million a year ago. Revenue was CNY 563.45 million compared to CNY 413.63 million a year ago. Net income was CNY 113.52 million compared to CNY 419.84 million a year ago. Basic earnings per share from continuing operations was CNY 0.36 compared to CNY 1.32 a year ago. Diluted earnings per share from continuing operations was CNY 0.36 compared to CNY 1.32 a year ago.
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
QINGDAO HAIER BIOMEDICAL CO.,LTD 
